Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 11 - Jul 16
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
GLP probiotic Akkarmansia Pounds Transformation Meet GSLIM: Safe GLP 1 Daily for Breastfeeding Mamas MilkDust for Moms Ro Online GLP 1 Clinic Review Vaccine Alliance Corrination of a GLP 1 Receptor Agonist for Glycemic Control without Emesis Hayes Lab Suicide and suicide attempt in users of GLP 1 receptor agonists: a nationwide case time control study eClinicalMedicine GLP 1s and GI Side Effects: How to Manage Symptoms
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.9 ★★★★★
Based on 1558 reviews
Sort
Product Reviews
★★★★★ 5
Impossible to put down.
Format: Hardcover
Possibly the best book written on this mostly neglected period In religious history.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 30, 2024
★★★★★ 5
awesome
Format: Kindle
awesome coverage of the period from post-exile to the NT. I really like the focus on the Davidic kingdom.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 1, 2025
★★★★★ 5
Great Research
Format: Hardcover
Excellent book. Great research and easy to read. Highly recommended.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 11, 2024
★★★★★ 3
Knowledgeable History; Uncharitable Theological Commentary
Format: Kindle
The author seems incredibly knowledgeable about the topic. I am learning a tremendous amount about the period bridging the Old and New Testament periods by reading this book. However, it is incredibly frustrating to me that the author compares modern day fellow-Christian cessationists with the unbelieving Sanhedrin whom Stephen excoriated in Acts chapter 7.
"The insinuation is that the Holy Spirit, which had inspired the Torah, was the very same spirit who had been prophetically active down to the time of Jesus but whom the Jewish leaders were now railing against. One wonders what words Stephen would have for modern readers who perpetuate the notion of prophetic silence."
At first this passage irritated me as an unnecessary and uncharitable jab. But I decided to write a review to let readers know to be prepared: if you do not have a Grudem-style view of ongoing prophecy, you should expect the author of this book to take cheap and uncharitable jabs, and to compare you to unbelieving Jews who rejected God's word. It actually colors my ability to take the author seriously, though I paid far too much for this book not to persevere through it.
The author could have chosen to take an objective and charitable stance and simply report the facts. I'm surprised an editor didn't encourage the author to restrain his criticisms.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 13, 2024
★★★★★ 5
a true blessing for Scriptural insight into God’s eternal plan !!
Format: Paperback
This book was extremely informative and helpful in understanding the Scriptures!!! Not only that,
it was hopeful and reassuring for the future!! I am so glad i bought this book!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 20, 2026
recommand products
1 Vial Starter Kit (10mg Melanotan)
25.07
Pfizer announces the advancement of the once-daily formulation development for the oral GLP-1 receptor agonist Danuglipron
24.72
Danuglipron: Pfizer's GLP-1 receptor agonist weight loss pill
21.93
PDB-101: Molecule of the Month: GLP-1 Receptor Agonists
28.72
In the same week that Pfizer decided to discontinue the development of danuglipron, an oral, small-molecule GLP-1 receptor agonist aimed at chronic weight management ➡️ Lilly report a successful Phase 3 trial
24.13